INS and COVID-19: Clinical reports have indicated that individuals with diabetes mellitus under COVID-19 often exhibit insulin resistance, accompanied by increased insulin concentrations in the blood.46 In the homogenate of pancreatic tissue from db mice, in situ FGF7 levels increased after SARS-CoV-2 infection (Fig. 5j).